Literature DB >> 34082174

Cervical cancer screening uptake in Sub-Saharan Africa: a systematic review and meta-analysis.

N B Yimer1, M A Mohammed2, K Solomon3, M Tadese2, S Grutzmacher4, H K Meikena5, B Alemnew6, N T Sharew7, T D Habtewold8.   

Abstract

OBJECTIVES: The objective of this study is to estimate the pooled uptake of cervical cancer screening and identify its predictors in Sub-Saharan Africa. STUDY
DESIGN: Systematic review and meta-analysis.
METHODS: We searched PubMed, EMBASE, CINAHL, African Journals OnLine, Web of Science and Scopus electronic databases from January 2000 to 2019. All observational studies published in the English language that reported cervical cancer uptake and/or predictors in Sub-Saharan Africa were initially screened. We assessed methodological quality using the Newcastle-Ottawa Scale. An inverse variance-weighted random-effects model meta-analysis was performed to estimate the pooled uptake and odds ratio (OR) of predictors with a 95% confidence interval (CI). The I2 test statistic was used to check between-study heterogeneity, and the Egger's regression statistical test was used to check publication bias.
RESULTS: We initially screened 3537 citations and subsequently 29 studies were selected for this review, which included a total of 36,374 women. The uptake of cervical cancer screening in Sub-Saharan Africa was 12.87% (95% CI: 10.20, 15.54; I2 = 98.5%). A meta-analysis of seven studies showed that knowledge about cervical cancer increased screening uptake by nearly five times (OR: 4.81; 95% CI: 3.06, 7.54). Other predictors of cervical screening uptake include educational level, age, Human Immune deficiency Virus (HIV) status, contraceptive use, perceived susceptibility and awareness about screening locations.
CONCLUSIONS: Cervical screening uptake is low in Sub-Saharan Africa as a result of several factors. Health outreach and promotion programmes to target these identified predictors are required.
Copyright © 2021 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Cervical cancer screening; Meta-analysis; Predictors; Sub-Sahara Africa

Year:  2021        PMID: 34082174     DOI: 10.1016/j.puhe.2021.04.014

Source DB:  PubMed          Journal:  Public Health        ISSN: 0033-3506            Impact factor:   2.427


  6 in total

Review 1.  Human Papillomavirus Vaccination in South Africa: Programmatic Challenges and Opportunities for Integration With Other Adolescent Health Services?

Authors:  Edina Amponsah-Dacosta; Ntombifuthi Blose; Varsetile Varster Nkwinika; Viola Chepkurui
Journal:  Front Public Health       Date:  2022-01-31

2.  Re-valuation of annual cytology using HPV self-sampling to upgrade prevention (REACH UP): A feasibility study in women living with HIV in the UK.

Authors:  Paola Cicconi; Charlotte Wells; Blanka McCarthy; Susan Wareing; Monique Ingrid Andersson; Julie Fox; Julianne Lwanga; Nisha Pal; Fiona Burns; Clare Woodward; Ramona Malek; Caroline Anne Sabin; Lucy Dorrell
Journal:  HIV Med       Date:  2022-03-03       Impact factor: 3.094

3.  Towards a cervical cancer-free future: women's healthcare decision making and cervical cancer screening uptake in sub-Saharan Africa.

Authors:  Joshua Okyere; Richard Gyan Aboagye; Abdul-Aziz Seidu; Bernard Yeboah-Asiamah Asare; Bupe Mwamba; Bright Opoku Ahinkorah
Journal:  BMJ Open       Date:  2022-07-29       Impact factor: 3.006

4.  Cervical cancer programme, Kenya, 2011-2020: lessons to guide elimination as a public health problem.

Authors:  Valerian Mwenda; Woki Mburu; Joan-Paula Bor; Mary Nyangasi; Marc Arbyn; Steven Weyers; Philippe Tummers; Marleen Temmerman
Journal:  Ecancermedicalscience       Date:  2022-08-26

5.  Brachytherapy infrastructure in sub-Saharan Africa and quest for cervical cancer elimination.

Authors:  Nuhu Tumba; Hadiza Theyra-Enias
Journal:  J Contemp Brachytherapy       Date:  2022-05-26

6.  Chemoradiation versus radiation alone in stage IIIB cervical cancer patients with or without human immunodeficiency virus.

Authors:  Surbhi Grover; Matthew S Ning; Michelle Bale; Katie E Lichter; Sidrah Shah; Memory Bvochora-Nsingo; Sebathu Chiyapo; Dawn Balang; Gwendolyn J McGinnis; Tlotlo Ralefala; Thabo Moloi; Rebecca Luckett; Doreen Ramogola-Masire; Erle S Robertson; Nicola M Zetola
Journal:  Int J Gynecol Cancer       Date:  2021-07-26       Impact factor: 3.437

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.